AZD-8186 Uses, Dosage, Side Effects and more
AZD-8186 is under investigation in clinical trial NCT03218826 (PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery).
| Trade Name | AZD-8186 |
| Generic | AZD-8186 |
| Type | |
| Formula | C24H25F2N3O4 |
| Weight | Average: 457.478 Monoisotopic: 457.181312623 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
